Neuropathy is a challenging long-term side-effect of weekly paclitaxel administration – the most commonly used regime for adjuvant treatment of early breast cancer, Australian research has shown. More than half of women who started on a course of paclitaxel reported numbness and tingling after six weeks, and the neuropathy persisted at 12 months, a NSW study ...
No easy answers for chemotherapy‐induced peripheral neuropathy
By Michael Woodhead
22 Feb 2021